43 results on '"Cassano, Enrico"'
Search Results
2. Preoperative breast MRI positively impacts surgical outcomes of needle biopsy–diagnosed pure DCIS: a patient-matched analysis from the MIPA study.
- Author
-
Cozzi, Andrea, Di Leo, Giovanni, Houssami, Nehmat, Gilbert, Fiona J., Helbich, Thomas H., Álvarez Benito, Marina, Balleyguier, Corinne, Bazzocchi, Massimo, Bult, Peter, Calabrese, Massimo, Camps Herrero, Julia, Cartia, Francesco, Cassano, Enrico, Clauser, Paola, de Lima Docema, Marcos F., Depretto, Catherine, Dominelli, Valeria, Forrai, Gábor, Girometti, Rossano, and Harms, Steven E.
- Subjects
- *
MAGNETIC resonance imaging , *CORE needle biopsy , *MAMMAPLASTY , *NONPARAMETRIC statistics , *CARCINOMA in situ , *DUCTAL carcinoma - Abstract
Objectives: To investigate the influence of preoperative breast MRI on mastectomy and reoperation rates in patients with pure ductal carcinoma in situ (DCIS). Methods: The MIPA observational study database (7245 patients) was searched for patients aged 18–80 years with pure unilateral DCIS diagnosed at core needle or vacuum-assisted biopsy (CNB/VAB) and planned for primary surgery. Patients who underwent preoperative MRI (MRI group) were matched (1:1) to those who did not receive MRI (noMRI group) according to 8 confounding covariates that drive referral to MRI (age; hormonal status; familial risk; posterior-to-nipple diameter; BI-RADS category; lesion diameter; lesion presentation; surgical planning at conventional imaging). Surgical outcomes were compared between the matched groups with nonparametric statistics after calculating odds ratios (ORs). Results: Of 1005 women with pure unilateral DCIS at CNB/VAB (507 MRI group, 498 noMRI group), 309 remained in each group after matching. First-line mastectomy rate in the MRI group was 20.1% (62/309 patients, OR 2.03) compared to 11.0% in the noMRI group (34/309 patients, p = 0.003). The reoperation rate was 10.0% in the MRI group (31/309, OR for reoperation 0.40) and 22.0% in the noMRI group (68/309, p < 0.001), with a 2.53 OR of avoiding reoperation in the MRI group. The overall mastectomy rate was 23.3% in the MRI group (72/309, OR 1.40) and 17.8% in the noMRI group (55/309, p = 0.111). Conclusions: Compared to those going directly to surgery, patients with pure DCIS at CNB/VAB who underwent preoperative MRI had a higher OR for first-line mastectomy but a substantially lower OR for reoperation. Clinical relevance statement: When confounding factors behind MRI referral are accounted for in the comparison of patients with CNB/VAB-diagnosed pure unilateral DCIS, preoperative MRI yields a reduction of reoperations that is more than twice as high as the increase in overall mastectomies. Key Points: • Confounding factors cause imbalance when investigating the influence of preoperative MRI on surgical outcomes of pure DCIS. • When patient matching is applied to women with pure unilateral DCIS, reoperation rates are significantly reduced in women who underwent preoperative MRI. • The reduction of reoperations brought about by preoperative MRI is more than double the increase in overall mastectomies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Patients' Perceptions and Attitudes to the Use of Artificial Intelligence in Breast Cancer Diagnosis: A Narrative Review.
- Author
-
Pesapane, Filippo, Giambersio, Emilia, Capetti, Benedetta, Monzani, Dario, Grasso, Roberto, Nicosia, Luca, Rotili, Anna, Sorce, Adriana, Meneghetti, Lorenza, Carriero, Serena, Santicchia, Sonia, Carrafiello, Gianpaolo, Pravettoni, Gabriella, and Cassano, Enrico
- Subjects
- *
PATIENTS' attitudes , *CANCER diagnosis , *ARTIFICIAL intelligence , *ATTITUDES toward technology , *PSYCHOLOGICAL factors , *HUMAN-artificial intelligence interaction - Abstract
Breast cancer remains the most prevalent cancer among women worldwide, necessitating advancements in diagnostic methods. The integration of artificial intelligence (AI) into mammography has shown promise in enhancing diagnostic accuracy. However, understanding patient perspectives, particularly considering the psychological impact of breast cancer diagnoses, is crucial. This narrative review synthesizes literature from 2000 to 2023 to examine breast cancer patients' attitudes towards AI in breast imaging, focusing on trust, acceptance, and demographic influences on these views. Methodologically, we employed a systematic literature search across databases such as PubMed, Embase, Medline, and Scopus, selecting studies that provided insights into patients' perceptions of AI in diagnostics. Our review included a sample of seven key studies after rigorous screening, reflecting varied patient trust and acceptance levels towards AI. Overall, we found a clear preference among patients for AI to augment rather than replace the diagnostic process, emphasizing the necessity of radiologists' expertise in conjunction with AI to enhance decision-making accuracy. This paper highlights the importance of aligning AI implementation in clinical settings with patient needs and expectations, emphasizing the need for human interaction in healthcare. Our findings advocate for a model where AI augments the diagnostic process, underlining the necessity for educational efforts to mitigate concerns and enhance patient trust in AI-enhanced diagnostics. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Atypical Ductal Hyperplasia and Lobular In Situ Neoplasm: High-Risk Lesions Challenging Breast Cancer Prevention.
- Author
-
Nicosia, Luca, Mariano, Luciano, Pellegrino, Giuseppe, Ferrari, Federica, Pesapane, Filippo, Bozzini, Anna Carla, Frassoni, Samuele, Bagnardi, Vincenzo, Pupo, Davide, Mazzarol, Giovanni, De Camilli, Elisa, Sangalli, Claudia, Venturini, Massimo, Pizzamiglio, Maria, and Cassano, Enrico
- Subjects
- *
BREAST surgery , *BREAST cancer surgery , *DISEASE progression , *STATISTICS , *BIOPSY , *CONFIDENCE intervals , *LOBULAR carcinoma , *LOG-rank test , *IMMUNOHISTOCHEMISTRY , *HEALTH outcome assessment , *RETROSPECTIVE studies , *FISHER exact test , *MAMMOGRAMS , *EARLY detection of cancer , *DUCTAL carcinoma , *DESCRIPTIVE statistics , *KAPLAN-Meier estimator , *CHI-squared test , *HEALTH care teams , *PROGRESSION-free survival , *DATA analysis software , *DATA analysis , *BREAST tumors , *CARCINOMA in situ , *EVALUATION - Abstract
Simple Summary: This retrospective study investigates histopathological outcomes, upgrade rates, and disease-free survival (DFS) in high-risk breast lesions, including atypical ductal hyperplasia (ADH or DIN1b) and lobular in situ neoplasms (LIN 1 and 2), following Vacuum-Assisted Breast Biopsy (VABB) and surgical excision. Focusing on 320 patients who underwent stereotactic VABB, with 246 individuals diagnosed with ADH (120) or LIN (126), the study addresses the challenge posed by these lesions due to their association with synchronous or adjacent Breast Cancer (BC) and increased future BC risk. The study underscores the importance of a multidisciplinary approach, acknowledging the evolving role of VABB, and emphasizes the need for careful follow-up, particularly for lobular lesions. It offers valuable insights for clinicians navigating the complex landscape of high-risk breast lesions, advocating for heightened awareness and vigilance in managing these lesions and contributing to the ongoing refinement of clinical strategies in BC care. This retrospective study investigates the histopathological outcomes, upgrade rates, and disease-free survival (DFS) of high-risk breast lesions, including atypical ductal hyperplasia (ADH or DIN1b) and lobular in situ neoplasms (LIN), following Vacuum-Assisted Breast Biopsy (VABB) and surgical excision. The study addresses the challenge posed by these lesions due to their association with synchronous or adjacent Breast Cancer (BC) and increased future BC risk. The research, comprising 320 patients who underwent stereotactic VABB, focuses on 246 individuals with a diagnosis of ADH (120) or LIN (126) observed at follow-up. Pathological assessments, categorized by the UK B-coding system, were conducted, and biopsy samples were compared with corresponding excision specimens to determine upgrade rates for in situ or invasive carcinoma. Surgical excision was consistently performed for diagnosed ADH or LIN. Finally, patient follow-ups were assessed and compared between LIN and ADH groups to identify recurrence signs, defined as histologically confirmed breast lesions on either the same or opposite side. The results reveal that 176 (71.5%) patients showed no upgrade post-surgery, with ADH exhibiting a higher upgrade rate to in situ pathology than LIN1 (Atypical Lobular Hyperplasia, ALH)/LIN2 (Low-Grade Lobular in situ Carcinoma, LCIS) (38% vs. 20%, respectively, p-value = 0.002). Considering only patients without upgrade, DFS at 10 years was 77%, 64%, and 72% for ADH, LIN1, and LIN2 patients, respectively (p-value = 0.92). The study underscores the importance of a multidisciplinary approach, recognizing the evolving role of VABB. It emphasizes the need for careful follow-up, particularly for lobular lesions, offering valuable insights for clinicians navigating the complex landscape of high-risk breast lesions. The findings advocate for heightened awareness and vigilance in managing these lesions, contributing to the ongoing refinement of clinical strategies in BC care. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Contrast-enhanced mammography BI-RADS: a case-based approach to radiology reporting.
- Author
-
Nicosia, Luca, Battaglia, Ottavia, Venturini, Massimo, Fontana, Federico, Minenna, Manuela, Pesenti, Aurora, Budascu, Diana, Pesapane, Filippo, Bozzini, Anna Carla, Pizzamiglio, Maria, Meneghetti, Lorenza, Latronico, Antuono, Signorelli, Giulia, Mariano, Luciano, and Cassano, Enrico
- Subjects
- *
MAMMOGRAMS , *BREAST imaging , *MEDICAL screening , *RADIOLOGY , *CANCER patients - Abstract
Contrast-enhanced mammography (CEM) is a relatively recent diagnostic technique increasingly being utilized in clinical practice. Until recently, there was a lack of standardized reporting for CEM findings. However, this has changed with the publication of a supplement in the Breast Imaging Reporting and Data System (BI-RADS). A comprehensive understanding of CEM is essential for further enhancing its role in both screening and managing patients with breast malignancies. CEM can also be beneficial for problem-solving, improving the management of uncertain breast findings. Practitioners in this field should become more cognizant of how and when to employ this technique and interpret the various CEM findings. This paper aims to outline the key findings in the updated version of the BI-RADS specifically dedicated to CEM. Additionally, it will present some clinical cases commonly encountered in clinical practice. Critical relevance statement Standardized reporting and a thorough understanding of CEM findings are pivotal for advancing the role of CEM in screening and managing breast cancer patients. This standardization contributes significantly to integrating CEM as an essential component of daily clinical practice. Key points • A complete knowledge and understanding of the findings outlined in the new BI-RADS CEM are necessary for accurate reporting. • BI-RADS CEM supplement is intuitive and practical to use. • Standardization of the CEM findings enables more accurate patient management. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Radiological Features of Male Breast Neoplasms: How to Improve the Management of a Rare Disease.
- Author
-
Nicosia, Luca, Mariano, Luciano, Bozzini, Anna Carla, Pesapane, Filippo, Bagnardi, Vincenzo, Frassoni, Samuele, Oriecuia, Chiara, Dominelli, Valeria, Latronico, Antuono, Palma, Simone, Venturini, Massimo, Fontana, Federico, Priolo, Francesca, Abiuso, Ida, Sangalli, Claudia, and Cassano, Enrico
- Subjects
- *
BREAST tumors , *MALE breast cancer , *DISEASE management , *RARE diseases , *GYNECOMASTIA , *DUCTAL carcinoma , *LOBULAR carcinoma - Abstract
The primary aim of our study was to assess the main mammographic and ultrasonographic features of invasive male breast malignancies. The secondary aim was to evaluate whether a specific radiological presentation would be associated with a worse receptor profile. Radiological images (mammography and/or ultrasound) of all patients who underwent surgery for male invasive breast cancer in our institution between 2008 and 2023 were retrospectively analyzed by two breast radiologists in consensus. All significant features of radiological presentation known in the literature were re-evaluated. Fifty-six patients were selected. The mean age at surgery of patients was 69 years (range: 35–81); in 82% of cases (46 patients), the histologic outcome was invasive ductal carcinoma. A total of 28 out of 56 (50%) patients had preoperative mammography; in 9/28 cases (32%), we found a mass with microcalcifications on mammography. The mass presented high density in 25 out of 28 patients (89%); the mass showed irregular margins in 15/28 (54%) cases. A total of 46 out of 56 patients had preoperative ultrasounds. The lesion showed a solid mass in 41/46 (89%) cases. In 5/46 patients (11%), the lesion was a mass with a mixed (partly liquid–partly solid) structure. We did not find any statistically significant correlation between major types of radiological presentation and tumor receptor arrangement. Knowledge of the main radiologic presentation patterns of malignant male breast neoplasm can help better manage this type of disease, which is rare but whose incidence is increasing. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Disparities in Breast Cancer Diagnostics: How Radiologists Can Level the Inequalities.
- Author
-
Pesapane, Filippo, Tantrige, Priyan, Rotili, Anna, Nicosia, Luca, Penco, Silvia, Bozzini, Anna Carla, Raimondi, Sara, Corso, Giovanni, Grasso, Roberto, Pravettoni, Gabriella, Gandini, Sara, and Cassano, Enrico
- Subjects
- *
BREAST tumor diagnosis , *OCCUPATIONAL roles , *HEALTH policy , *DIVERSITY & inclusion policies , *EQUALITY , *HEALTH services accessibility , *MINORITIES , *GENDER affirming care , *TELERADIOLOGY , *ARTIFICIAL intelligence , *RADIATION , *DIAGNOSTIC imaging , *LABOR supply , *CULTURAL competence , *HEALTH , *COMMUNICATION , *HEALTH equity , *PHYSICIANS , *ALGORITHMS - Abstract
Simple Summary: This paper delves into the persistent issue of unequal access to medical imaging, with a particular focus on breast cancer screening and its impact on marginalized communities and racial/ethnic minorities. Central to our discussion is the role of scientific mobility among radiologists in fostering healthcare policy changes that promote diversity and cultural competence. We propose various strategies to bridge this gap, including cultural education, sensitivity training, and diversifying the radiology workforce. These measures aim to improve communication with diverse patient groups and reduce healthcare disparities. Additionally, we explore the challenges and advantages of teleradiology as a means to extend medical imaging services to underserved areas. In the context of artificial intelligence, we emphasize the critical need to validate algorithms across diverse populations to ensure unbiased and equitable healthcare outcomes. Overall, this paper underscores the importance of international collaboration in addressing global access barriers, presenting it as a key to mitigating disparities in medical imaging access and contributing to the pursuit of equitable healthcare. Access to medical imaging is pivotal in healthcare, playing a crucial role in the prevention, diagnosis, and management of diseases. However, disparities persist in this scenario, disproportionately affecting marginalized communities, racial and ethnic minorities, and individuals facing linguistic or cultural barriers. This paper critically assesses methods to mitigate these disparities, with a focus on breast cancer screening. We underscore scientific mobility as a vital tool for radiologists to advocate for healthcare policy changes: it not only enhances diversity and cultural competence within the radiology community but also fosters international cooperation and knowledge exchange among healthcare institutions. Efforts to ensure cultural competency among radiologists are discussed, including ongoing cultural education, sensitivity training, and workforce diversification. These initiatives are key to improving patient communication and reducing healthcare disparities. This paper also highlights the crucial role of policy changes and legislation in promoting equal access to essential screening services like mammography. We explore the challenges and potential of teleradiology in improving access to medical imaging in remote and underserved areas. In the era of artificial intelligence, this paper emphasizes the necessity of validating its models across a spectrum of populations to prevent bias and achieve equitable healthcare outcomes. Finally, the importance of international collaboration is illustrated, showcasing its role in sharing insights and strategies to overcome global access barriers in medical imaging. Overall, this paper offers a comprehensive overview of the challenges related to disparities in medical imaging access and proposes actionable strategies to address these challenges, aiming for equitable healthcare delivery. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. A Pictorial Exploration of Mammary Paget Disease: Insights and Perspectives.
- Author
-
Mariano, Luciano, Nicosia, Luca, Pupo, Davide, Olivieri, Antonia Maria, Scolari, Sofia, Pesapane, Filippo, Latronico, Antuono, Bozzini, Anna Carla, Fusco, Nicola, Blanco, Marta Cruz, Mazzarol, Giovanni, Corso, Giovanni, Galimberti, Viviana Enrica, Venturini, Massimo, Pizzamiglio, Maria, and Cassano, Enrico
- Subjects
- *
BREAST tumor treatment , *BREAST cancer prognosis , *BREAST tumor diagnosis , *ADENOCARCINOMA , *IMMUNOHISTOCHEMISTRY , *MAGNETIC resonance imaging , *EARLY detection of cancer , *MAMMOGRAMS , *DUCTAL carcinoma , *BREAST cancer , *ADJUVANT treatment of cancer , *CHEMORADIOTHERAPY , *QUALITY of life , *BREAST , *BREAST tumors , *CARCINOMA in situ , *SYMPTOMS ,BODY fluid examination - Abstract
Simple Summary: This review provides a comprehensive overview of mammary Paget disease (MPD) from its historical origins to the current diagnostic and treatment strategies while also exploring promising avenues for future advancements in the field. With improved understanding and ongoing research efforts, we aim to enhance the prognosis and quality of life for individuals affected by this relatively uncommon condition. Mammary Paget disease (MPD) is a rare condition primarily affecting adult women, characterized by unilateral skin changes in the nipple–areolar complex (NAC) and frequently associated with underlying breast carcinoma. Histologically, MPD is identified by large intraepidermal epithelial cells (Paget cells) with distinct characteristics. Immunohistochemical profiles aid in distinguishing MPD from other skin conditions. Clinical evaluation and imaging techniques, including magnetic resonance imaging (MRI), are recommended if MPD is suspected, although definitive diagnosis always requires histological examination. This review delves into the historical context, epidemiology, pathogenesis, clinical manifestations, and diagnosis of MPD, emphasizing the need for early detection. The classification of MPD based on pathogenesis is explored, shedding light on its varied presentations. Treatment options, including mastectomy and breast-conserving surgery, are discussed with clear guidelines for different scenarios. Adjuvant therapies are considered, particularly in cases with underlying breast cancer. Prognostic factors are outlined, underlining the importance of early intervention. Looking to the future, emerging techniques, like liquid biopsy, new immunohistochemical and molecular markers, and artificial intelligence-based image analysis, hold the potential to transform MPD diagnosis and treatment. These innovations offer hope for early detection and improved patient care, though validation through large-scale clinical trials is needed. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. Screening and diagnostic breast MRI: how do they impact surgical treatment? Insights from the MIPA study.
- Author
-
Cozzi, Andrea, Di Leo, Giovanni, Houssami, Nehmat, Gilbert, Fiona J., Helbich, Thomas H., Álvarez Benito, Marina, Balleyguier, Corinne, Bazzocchi, Massimo, Bult, Peter, Calabrese, Massimo, Camps Herrero, Julia, Cartia, Francesco, Cassano, Enrico, Clauser, Paola, de Lima Docema, Marcos F., Depretto, Catherine, Dominelli, Valeria, Forrai, Gábor, Girometti, Rossano, and Harms, Steven E.
- Subjects
- *
MAGNETIC resonance mammography , *MEDICAL screening , *MAGNETIC resonance imaging , *BREAST exams , *REOPERATION , *MULTIVARIABLE testing - Abstract
Objectives: To report mastectomy and reoperation rates in women who had breast MRI for screening (S-MRI subgroup) or diagnostic (D-MRI subgroup) purposes, using multivariable analysis for investigating the role of MRI referral/nonreferral and other covariates in driving surgical outcomes. Methods: The MIPA observational study enrolled women aged 18–80 years with newly diagnosed breast cancer destined to have surgery as the primary treatment, in 27 centres worldwide. Mastectomy and reoperation rates were compared using non-parametric tests and multivariable analysis. Results: A total of 5828 patients entered analysis, 2763 (47.4%) did not undergo MRI (noMRI subgroup) and 3065 underwent MRI (52.6%); of the latter, 2441/3065 (79.7%) underwent MRI with preoperative intent (P-MRI subgroup), 510/3065 (16.6%) D-MRI, and 114/3065 S-MRI (3.7%). The reoperation rate was 10.5% for S-MRI, 8.2% for D-MRI, and 8.5% for P-MRI, while it was 11.7% for noMRI (p ≤ 0.023 for comparisons with D-MRI and P-MRI). The overall mastectomy rate (first-line mastectomy plus conversions from conserving surgery to mastectomy) was 39.5% for S-MRI, 36.2% for P-MRI, 24.1% for D-MRI, and 18.0% for noMRI. At multivariable analysis, using noMRI as reference, the odds ratios for overall mastectomy were 2.4 (p < 0.001) for S-MRI, 1.0 (p = 0.957) for D-MRI, and 1.9 (p < 0.001) for P-MRI. Conclusions: Patients from the D-MRI subgroup had the lowest overall mastectomy rate (24.1%) among MRI subgroups and the lowest reoperation rate (8.2%) together with P-MRI (8.5%). This analysis offers an insight into how the initial indication for MRI affects the subsequent surgical treatment of breast cancer. Key Points: • Of 3065 breast MRI examinations, 79.7% were performed with preoperative intent (P-MRI), 16.6% were diagnostic (D-MRI), and 3.7% were screening (S-MRI) examinations. • The D-MRI subgroup had the lowest mastectomy rate (24.1%) among MRI subgroups and the lowest reoperation rate (8.2%) together with P-MRI (8.5%). • The S-MRI subgroup had the highest mastectomy rate (39.5%) which aligns with higher-than-average risk in this subgroup, with a reoperation rate (10.5%) not significantly different to that of all other subgroups. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
10. An Unenhanced Breast MRI Protocol Based on Diffusion-Weighted Imaging: A Retrospective Single-Center Study on High-Risk Population for Breast Cancer.
- Author
-
Rotili, Anna, Pesapane, Filippo, Signorelli, Giulia, Penco, Silvia, Nicosia, Luca, Bozzini, Anna, Meneghetti, Lorenza, Zanzottera, Cristina, Mannucci, Sara, Bonanni, Bernardo, and Cassano, Enrico
- Subjects
- *
DIFFUSION magnetic resonance imaging , *MAGNETIC resonance imaging , *MEDICAL screening , *BREAST cancer , *BRCA genes - Abstract
Purpose: This study aimed to investigate the use of contrast-free magnetic resonance imaging (MRI) as an innovative screening method for detecting breast cancer in high-risk asymptomatic women. Specifically, the researchers evaluated the diagnostic performance of diffusion-weighted imaging (DWI) in this population. Methods: MR images from asymptomatic women, carriers of a germline mutation in either the BRCA1 or BRCA2 gene, collected in a single center from January 2019 to December 2021 were retrospectively evaluated. A radiologist with experience in breast imaging (R1) and a radiology resident (R2) independently evaluated DWI/ADC maps and, in case of doubts, T2-WI. The standard of reference was the pathological diagnosis through biopsy or surgery, or ≥1 year of clinical and radiological follow-up. Diagnostic performances were calculated for both readers with a 95% confidence interval (CI). The agreement was assessed using Cohen's kappa (κ) statistics. Results: Out of 313 women, 145 women were included (49.5 ± 12 years), totaling 344 breast MRIs with DWI/ADC maps. The per-exam cancer prevalence was 11/344 (3.2%). The sensitivity was 8/11 (73%; 95% CI: 46–99%) for R1 and 7/11 (64%; 95% CI: 35–92%) for R2. The specificity was 301/333 (90%; 95% CI: 87–94%) for both readers. The diagnostic accuracy was 90% for both readers. R1 recalled 40/344 exams (11.6%) and R2 recalled 39/344 exams (11.3%). Inter-reader reproducibility between readers was in moderate agreement (κ = 0.43). Conclusions: In female carriers of a BRCA1/2 mutation, breast DWI supplemented with T2-WI allowed breast cancer detection with high sensitivity and specificity by a radiologist with extensive experience in breast imaging, which is comparable to other screening tests. The findings suggest that DWI and T2-WI have the potential to serve as a stand-alone method for unenhanced breast MRI screening in a selected population, opening up new perspectives for prospective trials. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
11. Breast Digital Tomosynthesis versus Contrast-Enhanced Mammography: Comparison of Diagnostic Application and Radiation Dose in a Screening Setting.
- Author
-
Nicosia, Luca, Bozzini, Anna Carla, Pesapane, Filippo, Rotili, Anna, Marinucci, Irene, Signorelli, Giulia, Frassoni, Samuele, Bagnardi, Vincenzo, Origgi, Daniela, De Marco, Paolo, Abiuso, Ida, Sangalli, Claudia, Balestreri, Nicola, Corso, Giovanni, and Cassano, Enrico
- Subjects
- *
BREAST tumor risk factors , *BIOPSY , *MAMMOGRAMS , *CONTRAST media , *EARLY detection of cancer , *RISK assessment , *COMPARATIVE studies , *RADIATION doses , *BREAST tumors , *DIGITAL diagnostic imaging , *RADIATION dosimetry ,BREAST tumor prevention ,BREAST physiology - Abstract
Simple Summary: Screening mammography reduces mortality from breast malignancy. However, breast cancer screening is, unfortunately, hindered due to the poor sensitivity of mammography in dense breasts: up to 15–30% of all cancers may be missed. Given the rapid development of Contrast-Enhanced Mammography (CEM) and its potential for diagnostic use, even in an asymptomatic population, it seems very important to correctly assess the Average Glandular Dose (AGD) for a single CEM examination. Few studies have compared the AGD of CEM versus Digital Mammography (DM) and protocols, including Digital Breast Tomosynthesis (DBT) plus DM, in the same group of patients. The additional role of tomosynthesis versus digital mammography in asymptomatic patients with dense breasts in screening examinations has been well investigated with encouraging results. In this study, we intend to compare the AGD and the diagnostic performance of CEM versus DM, and of CEM versus DM + DBT, performed in the same group of patients over the same period of time in a screening setting. This study aims to evaluate the Average Glandular Dose (AGD) and diagnostic performance of CEM versus Digital Mammography (DM) as well as versus DM plus one-view Digital Breast Tomosynthesis (DBT), which were performed in the same patients at short intervals of time. A preventive screening examination in high-risk asymptomatic patients between 2020 and 2022 was performed with two-view Digital Mammography (DM) projections (Cranio Caudal and Medio Lateral) plus one Digital Breast Tomosynthesis (DBT) projection (mediolateral oblique, MLO) in a single session examination. For all patients in whom we found a suspicious lesion by using DM + DBT, we performed (within two weeks) a CEM examination. AGD and compression force were compared between the diagnostic methods. All lesions identified by DM + DBT were biopsied; then, we assessed whether lesions found by DBT were also highlighted by DM alone and/or by CEM. We enrolled 49 patients with 49 lesions in the study. The median AGD was lower for DM alone than for CEM (3.41 mGy vs. 4.24 mGy, p = 0.015). The AGD for CEM was significantly lower than for the DM plus one single projection DBT protocol (4.24 mGy vs. 5.55 mGy, p < 0.001). We did not find a statistically significant difference in the median compression force between the CEM and DM + DBT. DM + DBT allows the identification of one more invasive neoplasm one in situ lesion and two high-risk lesions, compared to DM alone. The CEM, compared to DM + DBT, failed to identify only one of the high-risk lesions. According to these results, CEM could be used in the screening of asymptomatic high-risk patients. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
12. How Radiomics Can Improve Breast Cancer Diagnosis and Treatment.
- Author
-
Pesapane, Filippo, De Marco, Paolo, Rapino, Anna, Lombardo, Eleonora, Nicosia, Luca, Tantrige, Priyan, Rotili, Anna, Bozzini, Anna Carla, Penco, Silvia, Dominelli, Valeria, Trentin, Chiara, Ferrari, Federica, Farina, Mariagiorgia, Meneghetti, Lorenza, Latronico, Antuono, Abbate, Francesca, Origgi, Daniela, Carrafiello, Gianpaolo, and Cassano, Enrico
- Subjects
- *
RADIOMICS , *CANCER diagnosis , *CANCER relapse , *SCIENTIFIC literature , *CANCER treatment , *COMPUTER-assisted image analysis (Medicine) - Abstract
Recent technological advances in the field of artificial intelligence hold promise in addressing medical challenges in breast cancer care, such as early diagnosis, cancer subtype determination and molecular profiling, prediction of lymph node metastases, and prognostication of treatment response and probability of recurrence. Radiomics is a quantitative approach to medical imaging, which aims to enhance the existing data available to clinicians by means of advanced mathematical analysis using artificial intelligence. Various published studies from different fields in imaging have highlighted the potential of radiomics to enhance clinical decision making. In this review, we describe the evolution of AI in breast imaging and its frontiers, focusing on handcrafted and deep learning radiomics. We present a typical workflow of a radiomics analysis and a practical "how-to" guide. Finally, we summarize the methodology and implementation of radiomics in breast cancer, based on the most recent scientific literature to help researchers and clinicians gain fundamental knowledge of this emerging technology. Alongside this, we discuss the current limitations of radiomics and challenges of integration into clinical practice with conceptual consistency, data curation, technical reproducibility, adequate accuracy, and clinical translation. The incorporation of radiomics with clinical, histopathological, and genomic information will enable physicians to move forward to a higher level of personalized management of patients with breast cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
13. Diagnostic performance of image-guided vacuum-assisted breast biopsy after neoadjuvant therapy for breast cancer: prospective pilot study.
- Author
-
Rossi, Elisabetta M. C., Invento, Alessandra, Pesapane, Filippo, Pagan, Eleonora, Bagnardi, Vincenzo, Fusco, Nicola, Venetis, Konstantinos, Dominelli, Valeria, Trentin, Chiara, Cassano, Enrico, Gilardi, Laura, Mazza, Manuelita, Lazzeroni, Matteo, De Lorenzi, Francesca, Caldarella, Pietro, De Scalzi, Alessandra, Girardi, Antonia, Sangalli, Claudia, Alberti, Luca, and Sacchini, Virgilio
- Subjects
- *
BREAST biopsy , *NEOADJUVANT chemotherapy , *EPIDERMAL growth factor receptors , *HER2 positive breast cancer , *BREAST cancer , *COLPOSCOPY - Abstract
Background: Image-guided vacuum-assisted breast biopsy (VABB) of the tumour bed, performed after neoadjuvant therapy, is increasingly being used to assess residual cancer and to potentially identify to identify pathological complete response (pCR). In this study, the accuracy of preoperative VABB specimens was assessed and compared with surgical specimens in patients with triple-negative or human epidermal growth factor receptor 2 (HER2)-positive invasive ductal breast cancer after neoadjuvant therapy. As a secondary endpoint, the performance of contrast-enhanced MRI of the breast and PET-CT for response prediction was assessed. Methods: This single-institution prospective pilot study enrolled patients from April 2018 to April 2021 with a complete response on imaging (iCR) who subsequently underwent VABB before surgery. Those with a pCR at VABB were included in the primary analysis of the accuracy of VABB. The performance of imaging (MRI and PET-CT) was analysed for prediction of a pCR considering both patients with an iCR and those with residual disease at postneoadjuvant therapy imaging. Results: Twenty patients were included in the primary analysis. The median age was 44 (range 35-51) years. At surgery, 18 of 20 patients showed a complete response (accuracy 90 (95 per cent exact c.i. 68 to 99) per cent). Only two patients showed residual ductal intraepithelial neoplasia of grade 2 and 3 respectively. In the secondary analysis, accuracy was similar for MRI and PET-CT (77 versus 78 per cent; P=0.76). Conclusion: VABB in patients with an iCR might be a promising method to select patients for de-escalation of surgical treatment in triple-negative or HER2-positive breast cancer. The present results support such an approach and should inform the design of future trials on de-escalation of surgery. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
14. Prediction of the Malignancy of a Breast Lesion Detected on Breast Ultrasound: Radiomics Applied to Clinical Practice.
- Author
-
Nicosia, Luca, Pesapane, Filippo, Bozzini, Anna Carla, Latronico, Antuono, Rotili, Anna, Ferrari, Federica, Signorelli, Giulia, Raimondi, Sara, Vignati, Silvano, Gaeta, Aurora, Bellerba, Federica, Origgi, Daniela, De Marco, Paolo, Castiglione Minischetti, Giuseppe, Sangalli, Claudia, Montesano, Marta, Palma, Simone, and Cassano, Enrico
- Subjects
- *
PROFESSIONAL practice , *CONFIDENCE intervals , *MULTIPLE regression analysis , *RETROSPECTIVE studies , *RISK assessment , *COMPUTER-aided diagnosis , *RECEIVER operating characteristic curves , *BREAST tumors - Abstract
Simple Summary: Breast cancer is the most frequent cancer among women: early diagnosis and management of breast lesions are crucial to achieve a better prognosis for patients with this diagnosis. Breast ultrasound (US) is one of the main techniques for the management of breast lesions and it is important in doubtful findings on mammography and in the evaluation of dense breasts. Unfortunately, US has a high rate of false positive and has high operator dependence. Ultrasound CAD (computer-aided diagnosis) and radiomics are newly developed tools that can help solve these issues: this study aims to create a radiomics score from breast US to predict malignancy of a breast lesion, and to also combine this score with CAD and sonographer performances. Finally, we would like to create a prediction tool of US radiomics features combined with CAD, clinical parameters, and Breast Imaging Reporting and Data System evaluation for the prediction of malignancy of breast lesions. The study aimed to evaluate the performance of radiomics features and one ultrasound CAD (computer-aided diagnosis) in the prediction of the malignancy of a breast lesion detected with ultrasound and to develop a nomogram incorporating radiomic score and available information on CAD performance, conventional Breast Imaging Reporting and Data System evaluation (BI-RADS), and clinical information. Data on 365 breast lesions referred for breast US with subsequent histologic analysis between January 2020 and March 2022 were retrospectively collected. Patients were randomly divided into a training group (n = 255) and a validation test group (n = 110). A radiomics score was generated from the US image. The CAD was performed in a subgroup of 209 cases. The radiomics score included seven radiomics features selected with the LASSO logistic regression model. The multivariable logistic model incorporating CAD performance, BI-RADS evaluation, clinical information, and radiomic score as covariates showed promising results in the prediction of the malignancy of breast lesions: Area under the receiver operating characteristic curve, [AUC]: 0.914; 95% Confidence Interval, [CI]: 0.876–0.951. A nomogram was developed based on these results for possible future applications in clinical practice. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
15. The Use of Artificial Intelligence (AI) in the Radiology Field: What Is the State of Doctor–Patient Communication in Cancer Diagnosis?
- Author
-
Derevianko, Alexandra, Pizzoli, Silvia Francesca Maria, Pesapane, Filippo, Rotili, Anna, Monzani, Dario, Grasso, Roberto, Cassano, Enrico, and Pravettoni, Gabriella
- Subjects
- *
TUMOR diagnosis , *ONLINE information services , *MEDICAL information storage & retrieval systems , *PHYSICIAN-patient relations , *ARTIFICIAL intelligence , *DESCRIPTIVE statistics , *HOSPITAL radiological services , *MEDLINE , *DATA analysis software , *MEDICAL specialties & specialists - Abstract
Simple Summary: Artificial Intelligence (AI) has been increasingly used in radiology to improve diagnostic procedures over the past decades. The application of AI at the time of cancer diagnosis also creates challenges in the way doctors should communicate the use of AI to patients. The present systematic review deals with the patient's psycho-cognitive perspective on AI and the interpersonal skills between patients and physicians when AI is implemented in cancer diagnosis communication. Evidence from the retrieved studies pointed out that the use of AI in radiology is negatively associated with patient trust in AI and patient-centered communication in cancer disease. Background: In the past decade, interest in applying Artificial Intelligence (AI) in radiology to improve diagnostic procedures increased. AI has potential benefits spanning all steps of the imaging chain, from the prescription of diagnostic tests to the communication of test reports. The use of AI in the field of radiology also poses challenges in doctor–patient communication at the time of the diagnosis. This systematic review focuses on the patient role and the interpersonal skills between patients and physicians when AI is implemented in cancer diagnosis communication. Methods: A systematic search was conducted on PubMed, Embase, Medline, Scopus, and PsycNet from 1990 to 2021. The search terms were: ("artificial intelligence" or "intelligence machine") and "communication" "radiology" and "oncology diagnosis". The PRISMA guidelines were followed. Results: 517 records were identified, and 5 papers met the inclusion criteria and were analyzed. Most of the articles emphasized the success of the technological support of AI in radiology at the expense of patient trust in AI and patient-centered communication in cancer disease. Practical implications and future guidelines were discussed according to the results. Conclusions: AI has proven to be beneficial in helping clinicians with diagnosis. Future research may improve patients' trust through adequate information about the advantageous use of AI and an increase in medical compliance with adequate training on doctor–patient diagnosis communication. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
16. Radiomic Features Applied to Contrast Enhancement Spectral Mammography: Possibility to Predict Breast Cancer Molecular Subtypes in a Non-Invasive Manner.
- Author
-
Nicosia, Luca, Bozzini, Anna Carla, Ballerini, Daniela, Palma, Simone, Pesapane, Filippo, Raimondi, Sara, Gaeta, Aurora, Bellerba, Federica, Origgi, Daniela, De Marco, Paolo, Castiglione Minischetti, Giuseppe, Sangalli, Claudia, Meneghetti, Lorenza, Curigliano, Giuseppe, and Cassano, Enrico
- Subjects
- *
MAMMOGRAMS , *BREAST , *BREAST cancer , *BREAST tumors , *LOGISTIC regression analysis , *KI-67 antigen - Abstract
We aimed to investigate the association between the radiomic features of contrast-enhanced spectral mammography (CESM) images and a specific receptor pattern of breast neoplasms. In this single-center retrospective study, we selected patients with neoplastic breast lesions who underwent CESM before a biopsy and surgical assessment between January 2013 and February 2022. Radiomic analysis was performed on regions of interest selected from recombined CESM images. The association between the features and each evaluated endpoint (ER, PR, Ki-67, HER2+, triple negative, G2–G3 expressions) was investigated through univariate logistic regression. Among the significant and highly correlated radiomic features, we selected only the one most associated with the endpoint. From a group of 321 patients, we enrolled 205 malignant breast lesions. The median age at the exam was 50 years (interquartile range (IQR) 45–58). NGLDM_Contrast was the only feature that was positively associated with both ER and PR expression (p-values = 0.01). NGLDM_Coarseness was negatively associated with Ki-67 expression (p-value = 0.02). Five features SHAPE Volume(mL), SHAPE_Volume(vx), GLRLM_RLNU, NGLDM_Busyness and GLZLM_GLNU were all positively and significantly associated with HER2+; however, all of them were highly correlated. Radiomic features of CESM images could be helpful to predict particular molecular subtypes before a biopsy. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
17. Digital Twins in Radiology.
- Author
-
Pesapane, Filippo, Rotili, Anna, Penco, Silvia, Nicosia, Luca, and Cassano, Enrico
- Subjects
- *
DIGITAL twins , *TELERADIOLOGY , *TECHNOLOGICAL innovations , *INDIVIDUALIZED medicine , *RADIOLOGY , *VIRTUAL reality - Abstract
A digital twin is a virtual model developed to accurately reflect a physical thing or a system. In radiology, a digital twin of a radiological device enables developers to test its characteristics, make alterations to the design or materials, and test the success or failure of the modifications in a virtual environment. Innovative technologies, such as AI and -omics sciences, may build virtual models for patients that are continuously adjustable based on live-tracked health/lifestyle parameters. Accordingly, healthcare could use digital twins to improve personalized medicine. Furthermore, the accumulation of digital twin models from real-world deployments will enable large cohorts of digital patients that may be used for virtual clinical trials and population studies. Through their further refinement, development, and application into clinical practice, digital twins could be crucial in the era of personalized medicine, revolutionizing how diseases are detected and managed. Although significant challenges remain in the development of digital twins, a structural modification to the current operating models is occurring, and radiologists can guide the introduction of such technology into healthcare. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
18. A Score to Predict the Malignancy of a Breast Lesion Based on Different Contrast Enhancement Patterns in Contrast-Enhanced Spectral Mammography.
- Author
-
Nicosia, Luca, Bozzini, Anna Carla, Palma, Simone, Montesano, Marta, Pesapane, Filippo, Ferrari, Federica, Dominelli, Valeria, Rotili, Anna, Meneghetti, Lorenza, Frassoni, Samuele, Bagnardi, Vincenzo, Sangalli, Claudia, and Cassano, Enrico
- Subjects
- *
BREAST tumor diagnosis , *CONFIDENCE intervals , *MAMMOGRAMS , *CONTRAST media , *DIAGNOSTIC imaging , *DESCRIPTIVE statistics , *DATA analysis software , *SENSITIVITY & specificity (Statistics) - Abstract
Simple Summary: Contrast-enhanced spectral mammography (CESM) represents a novel, reliable imaging adjunct for the early detection and management of breast lesions by coupling high sensitivity and specificity. Early diagnosis of breast tumors using this innovative diagnostic method could help in reducing the high number of unnecessary biopsies for breast lesions considered as suspicious by standard radiological examination (such as mammography, ultrasound, and magnetic resonance). Considering its relative recent introduction, there are still no standardized methods for assessing the diagnostic performance of CESM enhancement descriptors. Here, we aim to create a score that takes account four CESM enhancement descriptors able to efficiently predict the malignancy of a breast lesion prior to biopsy. Background: To create a predictive score of malignancy of a breast lesion based on the main contrast enhancement features ascertained by contrast-enhanced spectral mammography (CESM). Methods: In this single-centre prospective study, patients with suspicious breast lesions (BIRADS > 3) were enrolled between January 2013 and February 2022. All participants underwent CESM prior to breast biopsy, and eventually surgery. A radiologist with 20 years' experience in breast imaging evaluated the presence or absence of enhancement and the following enhancement descriptors: intensity, pattern, margin, and ground glass. A score of 0 or 1 was given for each descriptor, depending on whether the enhancement characteristic was predictive of benignity or malignancy (both in situ and invasive). Then, an overall enhancement score ranging from 0 to 4 was obtained. The histological results were considered the gold standard in the evaluation of the relationship between enhancement patterns and malignancy. Results: A total of 321 women (median age: 51 years; range: 22–83) with 377 suspicious breast lesions were evaluated. Two hundred forty-nine lesions (66%) have malignant histological results (217 invasive and 32 in situ). Considering an overall enhancement score ≥ 2 as predictive of malignancy, we obtain an overall sensitivity of 92.4%; specificity of 89.8%; positive predictive value of 94.7%; and negative predictive value of 85.8%. Conclusions: Our proposed predictive score on the enhancement descriptors of CESM to predict the malignancy of a breast lesion shows excellent results and can help in early breast cancer diagnosis and in avoiding unnecessary biopsies. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
19. Magnetic resonance imaging before breast cancer surgery: results of an observational multicenter international prospective analysis (MIPA).
- Author
-
Sardanelli, Francesco, Trimboli, Rubina M., Houssami, Nehmat, Gilbert, Fiona J., Helbich, Thomas H., Álvarez Benito, Marina, Balleyguier, Corinne, Bazzocchi, Massimo, Bult, Peter, Calabrese, Massimo, Camps Herrero, Julia, Cartia, Francesco, Cassano, Enrico, Clauser, Paola, Cozzi, Andrea, de Andrade, Danúbia A., de Lima Docema, Marcos F., Depretto, Catherine, Dominelli, Valeria, and Forrai, Gábor
- Abstract
Objectives: Preoperative breast magnetic resonance imaging (MRI) can inform surgical planning but might cause overtreatment by increasing the mastectomy rate. The Multicenter International Prospective Analysis (MIPA) study investigated this controversial issue. Methods: This observational study enrolled women aged 18–80 years with biopsy-proven breast cancer, who underwent MRI in addition to conventional imaging (mammography and/or breast ultrasonography) or conventional imaging alone before surgery as routine practice at 27 centers. Exclusion criteria included planned neoadjuvant therapy, pregnancy, personal history of any cancer, and distant metastases. Results: Of 5896 analyzed patients, 2763 (46.9%) had conventional imaging only (noMRI group), and 3133 (53.1%) underwent MRI that was performed for diagnosis, screening, or unknown purposes in 692/3133 women (22.1%), with preoperative intent in 2441/3133 women (77.9%, MRI group). Patients in the MRI group were younger, had denser breasts, more cancers ≥ 20 mm, and a higher rate of invasive lobular histology than patients who underwent conventional imaging alone (p < 0.001 for all comparisons). Mastectomy was planned based on conventional imaging in 22.4% (MRI group) versus 14.4% (noMRI group) (p < 0.001). The additional planned mastectomy rate in the MRI group was 11.3%. The overall performed first- plus second-line mastectomy rate was 36.3% (MRI group) versus 18.0% (noMRI group) (p < 0.001). In women receiving conserving surgery, MRI group had a significantly lower reoperation rate (8.5% versus 11.7%, p < 0.001). Conclusions: Clinicians requested breast MRI for women with a higher a priori probability of receiving mastectomy. MRI was associated with 11.3% more mastectomies, and with 3.2% fewer reoperations in the breast conservation subgroup. Key Points: • In 19% of patients of the MIPA study, breast MRI was performed for screening or diagnostic purposes. • The current patient selection to preoperative breast MRI implies an 11% increase in mastectomies, counterbalanced by a 3% reduction of the reoperation rate. • Data from the MIPA study can support discussion in tumor boards when preoperative MRI is under consideration and should be shared with patients to achieve informed decision-making. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
20. Evaluation of computer-aided diagnosis in breast ultrasonography: Improvement in diagnostic performance of inexperienced radiologists.
- Author
-
Nicosia, Luca, Addante, Francesca, Bozzini, Anna Carla, Latronico, Antuono, Montesano, Marta, Meneghetti, Lorenza, Tettamanzi, Francesca, Frassoni, Samuele, Bagnardi, Vincenzo, De Santis, Rossella, Pesapane, Filippo, Fodor, Cristiana Iuliana, Mastropasqua, Mauro Giuseppe, and Cassano, Enrico
- Subjects
- *
BREAST , *COMPUTER-aided diagnosis , *DIAGNOSTIC ultrasonic imaging , *BREAST ultrasound , *RADIOLOGISTS , *BREAST cancer , *STRESS echocardiography - Abstract
To evaluate if a computer-aided diagnosis (CAD) system on ultrasound (US) can improve the diagnostic performance of inexperienced radiologists. We collected ultrasound images of 256 breast lesions taken between March and May 2020. We asked two experienced and two inexperienced radiologists to retrospectively review the US features of each breast lesion according to the Breast Imaging Reporting and Data System (BI-RADS) categories. A CAD examination with S-Detect™ software (Samsung Healthcare, Seoul, South Korea) was conducted retrospectively by another uninvolved radiologist blinded to the BIRADS values previously attributed to the lesions. Diagnostic performances of experienced and inexperienced radiologists and CAD were compared and the inter-observer agreement among radiologists was calculated. The diagnostic performance of the experienced group in terms of sensitivity was significantly higher than CAD (p < 0.001). Conversely, the diagnostic performance of inexperienced group in terms of both sensitivity and specificity was significantly lower than CAD (p < 0.001). We obtained an excellent agreement in the evaluation of the lesions among the two expert radiologists (Kappa coefficient: 88.7%), and among the two non-expert radiologists (Kappa coefficient: 84.9%). The US CAD system is a useful additional tool to improve the diagnostic performance of the inexperienced radiologists, eventually reducing the number of unnecessary biopsies. Moreover, it is a valid second opinion in case of experienced radiologists. • Breast ultrasound (US) is an essential imaging tool for breast cancer detection in women with dense breast. • New generation ultrasound machines try to include software that can automatically evaluate the risk of malignancy. • Computer-aided diagnosis system on ultrasound can improve the diagnostic performance of inexperienced radiologists. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
21. Evolving paradigms in breast cancer screening: Balancing efficacy, personalization, and equity.
- Author
-
Pesapane, Filippo, Rotili, Anna, Raimondi, Sara, Aurilio, Gaetano, Lazzeroni, Matteo, Nicosia, Luca, Latronico, Antuono, Pizzamiglio, Maria, Cassano, Enrico, and Gandini, Sara
- Abstract
• Breast screening needs a critical balance of early detection and risk of overtreatment. • AI integration elevates diagnostic precision in breast cancer screening. • Emphasis on personalized approaches in screening mitigate risks of overtreatment. • Emerging imaging technologies may significantly improve early cancer detection. • Ensuring equitable access to breast cancer screening is vital for diverse populations. Breast cancer remains a significant global health challenge, with projections indicating a troubling increase in incidence. Breast cancer screening programs have long been hailed as life-saving initiatives, yet their true impact on mortality rates is a subject of ongoing debate. Screening poses the risk of false positives and the detection of indolent tumors, potentially leading to overtreatment. Bias factors, including lead time, length time, and selection biases, further complicate the assessment of screening efficacy. Recent studies suggest that AI-driven image analysis may revolutionize breast cancer screening, maintaining diagnostic accuracy while reducing radiologists' workload. However, the generalizability of these findings to diverse populations is a critical consideration. Personalized screening approaches and equitable access to advanced technologies are essential to mitigate disparities. In conclusion, the breast cancer screening landscape is evolving, emphasizing the need for risk stratification, appropriate imaging modalities, and a personalized approach to reduce overdiagnosis and focus on cancers with the potential to impact lives while prioritizing patient-centered care. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. MRI features of breast implant-associated anaplastic large cell lymphoma.
- Author
-
Rotili, Anna, Ferrari, Federica, Nicosia, Luca, Pesapane, Filippo, Tabanelli, Valentina, Fiori, Stefano, Vanazzi, Anna, Meneghetti, Lorenza, Abbate, Francesca, Latronico, Antuono, and Cassano, Enrico
- Subjects
- *
ANAPLASTIC large-cell lymphoma , *BREAST , *CD30 antigen , *NON-Hodgkin's lymphoma , *MAGNETIC resonance imaging , *BREAST implants , *BREAST cancer - Abstract
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare and newly recognized subtype of T cell Non-Hodgkin Lymphoma (NHLs) associated with breast implants. The mechanism involved in the development of this kind of lymphoma is still uncertain. BIA-ALCL is generally an indolent disease localized to the breast implant and its capsule and effectively treated with capsulectomy alone without chemotherapy. Clinically, BIA-ALCL may typically present a sudden-onset breast-swelling secondary to periimplant effusion. The minority of BIA-ALCL patients present a more aggressive mass-forming subtype, for which systemic therapy is mandatory. Despite the number of cases has recently increased, BIA-ALCL remains a rare disease described mainly in several case reports and small case series. Breast imaging, including mammography, ultrasound and breast MRI are routinely used in the screening of breast cancer; however, guidelines for the imaging and pathological diagnosis of this disease have only recently been proposed and included in the 2019 National Comprehensive Cancer Network (NCCN) consensus guidelines for BIA-ALCL. The main purpose of this pictorial is to illustrate the MRI signs of BIA-ALCL and correlate them with the corresponding pathology features in order to improve the knowledge of the principals MRI features of this type of lymphoma. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
23. Recent Radiomics Advancements in Breast Cancer: Lessons and Pitfalls for the Next Future.
- Author
-
Pesapane, Filippo, Rotili, Anna, Maria Agazzi, Giorgio, Botta, Francesca, Raimondi, Sara, Penco, Silvia, Dominelli, Valeria, Cremonesi, Marta, Alicja Jereczek-Fossa, Barbara, Carrafiello, Gianpaolo, and Cassano, Enrico
- Subjects
- *
RADIOMICS , *BREAST cancer , *MEDICAL personnel , *LYMPH node cancer , *PROGNOSIS , *NEOADJUVANT chemotherapy , *LYMPHATIC metastasis - Abstract
Radiomics is an emerging translational field of medicine based on the extraction of highdimensional data from radiological images, with the purpose to reach reliable models to be applied into clinical practice for the purposes of diagnosis, prognosis and evaluation of disease response to treatment. We aim to provide the basic information on radiomics to radiologists and clinicians who are focused on breast cancer care, encouraging cooperation with scientists to mine data for a better application in clinical practice. We investigate the workflow and clinical application of radiomics in breast cancer care, as well as the outlook and challenges based on recent studies. Currently, radiomics has the potential ability to distinguish between benign and malignant breast lesions, to predict breast cancer's molecular subtypes, the response to neoadjuvant chemotherapy and the lymph node metastases. Even though radiomics has been used in tumor diagnosis and prognosis, it is still in the research phase and some challenges need to be faced to obtain a clinical translation. In this review, we discuss the current limitations and promises of radiomics for improvement in further research. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
24. Wireless ultrasound‐guided vacuum‐assisted breast biopsy: Experience in clinical practice at European Institute of Oncology.
- Author
-
Nicosia, Luca, Bozzini, Anna, Addante, Francesca, Renne, Giuseppe, Latronico, Antuono, Meneghetti, Lorenza, Pala, Oriana, Frassoni, Samuele, Bagnardi, Vincenzo, Cassano, Enrico, and Mastropasqua, Mauro Giuseppe
- Subjects
- *
BREAST ultrasound , *ULTRASONIC imaging equipment , *PATIENT aftercare , *PREDICTIVE tests , *BIOPSY , *LONGITUDINAL method , *NEEDLE biopsy - Abstract
In the last few years, ultrasound‐guided vacuum‐assisted breast biopsy (US‐VABB) has replaced surgical biopsy due to higher diagnostic accuracy and lower patient discomfort, and, at present, an even greater possibility is represented by the new wireless ultrasound‐guided VAB device (Wi‐UVAB). The purpose of our study is to determine the diagnostic accuracy of this new device in a sizeable representative number of patients. From January 2014 to June 2018, 168 biopsies were performed in our institution using the new Wi‐UVAB device. We analyzed sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy of biopsies obtained with the new device using surgical results as reference point, following patients for at least one year. In our cohort, we obtained a complete sensitivity of 97.5%, an absolute sensitivity of 94.3%, a complete specificity of 98%, and an absolute specificity of 98%. The positive predictive value of the procedure was 97.5% while the negative predictive value was 98%. The diagnostic accuracy was 98%. The Wi‐UVAB is a safe procedure with high diagnostic accuracy, comparable to that of the traditional vacuum‐assisted breast biopsy and even higher than that of core needle biopsy (CNB). Moreover, the Wi‐UVAB is easy to use and shows low costs as core needle biopsy (CNB). [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
25. COVID‐19 and breast fine needle aspiration cytology method: What should we change?
- Author
-
Nicosia, Luca, Bozzini, Anna Carla, Latronico, Antuono, Addante, Francesca, Mastropasqua, Mauro Giuseppe, Meneghetti, Lorenza, Mauri, Giovanni, De Fiori, Elvio, Montesano, Marta, Di Tonno, Clementina, Midolo De Luca, Valeria, Casadio, Chiara, and Cassano, Enrico
- Subjects
- *
NEEDLE biopsy , *COVID-19 , *CYTOLOGY , *CHI-squared test , *HOSPITAL laboratories - Abstract
Introduction: Air‐dried slide preparation for fine needle aspiration cytology procedures is currently considered unsafe because of the risk of infectious aerosols of coronavirus 19. This study compares the safety and accuracy of two different protocols, one with and one without air‐dried slides. Methods: Starting from 3 March 2020, we discontinued the use of air‐dried slides during breast fine needle aspiration procedures. We selected cases collected during two periods: 2 months before and 2 months after 3 March. In both groups, the number of procedures was recorded together with the distribution of the diagnostic categories and the concordance between cytological and histological results on surgical specimens for lesions suggestive of malignancy, using the chi‐squared test. Results: Of the 100 procedures performed during the pre‐COVID‐19 period, 55% were negative (C2), 3% were non‐diagnostic (C1) and 40% were positive (C4 or C5). Of the 75 procedures obtained during the COVID‐19 period, 44% were negative (C2), 2.7% were non‐diagnostic (C1) and 52% were positive (C4 or C5). Despite the use of a new protocol during the COVID‐19 period, we observed concordance between cytological and histological results for lesions suggestive of malignancy. There was no statistically significant difference concerning the distribution of the diagnostic categories in the two groups. Conclusions: Taking into account the slightly lower number of procedures being analysed during the COVID‐19 period, the introduction of a new protocol that does not include air‐dried slides is safe and reliable. The pandemic period due to COVID19 has changed many methods in routine hospital and laboratory practice. Air‐dried slides, due to their risky preparation, should be avoided but cytologists lose the optimal definition of cytoplasmic and nuclear features provided by that method of preparation. A new protocol was introduced in our practice that appears to be safe and reliable. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
26. The potential role of contrast-enhanced mammography in downgrading BI-RADS 4 lesions: A balanced perspective.
- Author
-
Pesapane, Filippo, Rotili, Anna, Dominelli, Valeria, and Cassano, Enrico
- Subjects
- *
MAMMOGRAMS - Published
- 2023
- Full Text
- View/download PDF
27. Solving the preoperative breast MRI conundrum: design and protocol of the MIPA study.
- Author
-
Sardanelli, Francesco, Trimboli, Rubina M., Houssami, Nehmat, Gilbert, Fiona J., Helbich, Thomas H., Alvarez Benito, Marina, Balleyguier, Corinne, Bazzocchi, Massimo, Bult, Peter, Calabrese, Massimo, Camps Herrero, Julia, Cartia, Francesco, Cassano, Enrico, Clauser, Paola, de Andrade, Danubia A., de Lima Docema, Marcos F., Depretto, Catherine, Forrai, Gabor, Girometti, Rossano, and Harms, Steven E.
- Subjects
- *
MAGNETIC resonance mammography , *BREAST , *BREAST cancer , *CANCER patients , *LUMPECTOMY - Abstract
Despite its high diagnostic performance, the use of breast MRI in the preoperative setting is controversial. It has the potential for personalized surgical management in breast cancer patients, but two of three randomized controlled trials did not show results in favor of its introduction for assessing the disease extent before surgery. Meta-analyses showed a higher mastectomy rate in women undergoing preoperative MRI compared to those who do not. Nevertheless, preoperative breast MRI is increasingly used and a survey from the American Society of Breast Surgeons showed that 41% of respondents ask for it in daily practice. In this context, a large-scale observational multicenter international prospective analysis (MIPA study) was proposed under the guidance of the European Network for the Assessment of Imaging in Medicine (EuroAIM). The aims were (1) to prospectively and systematically collect data on consecutive women with a newly diagnosed breast cancer, not candidates for neoadjuvant therapy, who are offered or not offered breast MRI before surgery according to local practice; (2) to compare these two groups in terms of surgical and clinical endpoints, adjusting for covariates. The underlying hypotheses are that MRI does not cause additional mastectomies compared to conventional imaging, while reducing the reoperation rate in all or in subgroups of patients. Ninety-six centers applied to a web-based call; 36 were initially selected based on volume and quality standards; 27 were active for enrollment. On November 2018, the target of 7000 enrolled patients was reached. The MIPA study is presently at the analytic phase. Key Points • Breast MRI has a high diagnostic performance but its utility in the preoperative setting is controversial. • A large-scale observational multicenter prospective study was launched to compare women receiving with those not receiving preoperative MRI. • Twenty-seven centers enrolled more than 7000 patients. The study is presently at the analytic phase. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
28. Imaging diagnosis of metastatic breast cancer.
- Author
-
Pesapane, Filippo, Downey, Kate, Rotili, Anna, Cassano, Enrico, and Koh, Dow-Mu
- Subjects
- *
METASTATIC breast cancer , *CANCER diagnosis , *BREAST cancer , *RADIONUCLIDE imaging , *BONES - Abstract
Numerous imaging modalities may be used for the staging of women with advanced breast cancer. Although bone scintigraphy and multiplanar-CT are the most frequently used tests, others including PET, MRI and hybrid scans are also utilised, with no specific recommendations of which test should be preferentially used. We review the evidence behind the imaging modalities that characterise metastases in breast cancer and to update the evidence on comparative imaging accuracy. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
29. Image-guided breast biopsy and localisation: recommendations for information to women and referring physicians by the European Society of Breast Imaging.
- Author
-
Bick, Ulrich, Trimboli, Rubina M., Athanasiou, Alexandra, Balleyguier, Corinne, Baltzer, Pascal A. T., Bernathova, Maria, Borbély, Krisztina, Brkljacic, Boris, Carbonaro, Luca A., Clauser, Paola, Cassano, Enrico, Colin, Catherine, Esen, Gul, Evans, Andrew, Fallenberg, Eva M., Fuchsjaeger, Michael H., Gilbert, Fiona J., Helbich, Thomas H., Heywang-Köbrunner, Sylvia H., and Herranz, Michel
- Subjects
- *
BREAST biopsy , *MAGNETIC resonance mammography , *CORE needle biopsy , *BREAST imaging , *DIAGNOSTIC ultrasonic imaging personnel , *TOMOSYNTHESIS , *NEEDLE biopsy , *WOMEN physicians , *MAGNETIC resonance imaging - Abstract
We summarise here the information to be provided to women and referring physicians about percutaneous breast biopsy and lesion localisation under imaging guidance. After explaining why a preoperative diagnosis with a percutaneous biopsy is preferred to surgical biopsy, we illustrate the criteria used by radiologists for choosing the most appropriate combination of device type for sampling and imaging technique for guidance. Then, we describe the commonly used devices, from fine-needle sampling to tissue biopsy with larger needles, namely core needle biopsy and vacuum-assisted biopsy, and how mammography, digital breast tomosynthesis, ultrasound, or magnetic resonance imaging work for targeting the lesion for sampling or localisation. The differences among the techniques available for localisation (carbon marking, metallic wire, radiotracer injection, radioactive seed, and magnetic seed localisation) are illustrated. Type and rate of possible complications are described and the issue of concomitant antiplatelet or anticoagulant therapy is also addressed. The importance of pathological-radiological correlation is highlighted: when evaluating the results of any needle sampling, the radiologist must check the concordance between the cytology/pathology report of the sample and the radiological appearance of the biopsied lesion. We recommend that special attention is paid to a proper and tactful approach when communicating to the woman the need for tissue sampling as well as the possibility of cancer diagnosis, repeat tissue sampling, and or even surgery when tissue sampling shows a lesion with uncertain malignant potential (also referred to as "high-risk" or B3 lesions). Finally, seven frequently asked questions are answered. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
30. Solitary breast neurofibroma: imaging aspects.
- Author
-
Rotili, Anna, De Maria, Federica, Di Venosa, Benedetta, Ghioni, Mariacristina, Pizzamiglio, Maria, Cassano, Enrico, and Moratti, Michela
- Subjects
- *
BREAST diseases , *NEUROFIBROMA , *MAGNETIC resonance imaging - Abstract
Neurofibromas are benign peripheral nerve sheath tumours, which are usually solitary and sporadic. Solitary neurofibromas of the breast are rare. The most common location of a breast neurofibroma is the nipple–areola complex. We report a rare case of a 56-year-old woman with a solitary neurofibroma of the right breast sulcus. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
31. Women's perceptions and attitudes to the use of AI in breast cancer screening: a survey in a cancer referral centre.
- Author
-
Pesapane, Filippo, Rotili, Anna, Valconi, Elena, Agazzi, Giorgio Maria, Montesano, Marta, Penco, Silvia, Nicosia, Luca, Bozzini, Anna, Meneghetti, Lorenza, Latronico, Antuono, Pizzamiglio, Maria, Rossero, Eleonora, Gaeta, Aurora, Raimondi, Sara, Pizzoli, Silvia Francesca Maria, Grasso, Roberto, Carrafiello, Gianpaolo, Pravettoni, Gabriella, and Cassano, Enrico
- Subjects
- *
WOMEN'S attitudes , *EARLY detection of cancer , *BREAST cancer , *ARTIFICIAL intelligence - Abstract
Objective: Although breast cancer screening can benefit from Artificial Intelligence (AI), it is still unknown whether, to which extent or under which conditions, the use of AI is going to be accepted by the general population. The aim of our study is to evaluate what the females who are eligible for breast cancer screening know about AI and how they perceive such innovation. Methods: We used a prospective survey consisting of a 11‐multiple‐choice questionnaire evaluating statistical associations with Chi‐Square‐test or Fisher‐exact‐test. Multinomial‐logistic‐regression was performed on items with more than two response categories. Odds ratio (OR) with 95% CI were computed to estimate the probability of a specific response according to patient's characteristics. Results: In the 800 analysed questionnaires, 51% of respondents confirmed to have knowledge of AI. Of these, 88% expressed a positive opinion about its use in medicine. Non‐Italian respondents were associated with the belief of having a deep awareness about AI more often than Italian respondents (OR = 1.91;95% CI[1.10–3.33]). Higher education level was associated with better opinions on the use of AI in medicine (OR = 4.69;95% CI[1.36–16.12]). According to 94% of respondents, the radiologists should always produce their own report on mammograms, whilst 77% agreed that AI should be used as a second reader. Most respondents (52%) considered that both the software developer and the radiologist should be held accountable for AI errors. Conclusions: Most of the females undergoing screening in our Institute approve the introduction of AI, although only as a support to radiologist, and not in substitution thereof. Yet, accountability in case of AI errors is still unsolved. advances in knowledge: This survey may be considered as a pilot‐study for the development of large‐scale studies to understand females's demands and concerns about AI applications in breast cancer screening. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
32. Breast Tissue Composition and Its Dependence on Demographic Risk Factors for Breast Cancer: Non-Invasive Assessment by Time Domain Diffuse Optical Spectroscopy.
- Author
-
Taroni, Paola, Quarto, Giovanna, Pifferi, Antonio, Abbate, Francesca, Balestreri, Nicola, Menna, Simona, Cassano, Enrico, and Cubeddu, Rinaldo
- Subjects
- *
BREAST cancer risk factors , *TIME-domain analysis , *OPTICAL spectroscopy , *MAMMOGRAMS , *IONIZING radiation , *BODY mass index , *PERIMENOPAUSE - Abstract
Background: Breast tissue composition is recognized as a strong and independent risk factor for breast cancer. It is a heritable feature, but is also significantly affected by several other elements (e.g., age, menopause). Nowadays it is quantified by mammographic density, thus requiring the use of ionizing radiation. Optical techniques are absolutely non-invasive and have already proved effective in the investigation of biological tissues, as they are sensitive to tissue composition and structure. Methods: Time domain diffuse optical spectroscopy was performed at 7 wavelengths (635-1060 nm) on 200 subjects to derive their breast tissue composition (in terms of water, lipid and collagen content), blood parameters (total hemoglobin content and oxygen saturation level), and information on the microscopic structure (scattering amplitude and power). The dependence of all optically-derived parameters on age, menopausal status, body mass index, and use of oral contraceptives, and the correlation with mammographic density were investigated. Results: Younger age, premenopausal status, lower body mass index values, and use of oral contraceptives all correspond to significantly higher water, collagen and total hemoglobin content, and lower lipid content (always p < 0.05 and often p < 10-4), while oxygen saturation level and scattering parameters show significant dependence only on some conditions. Even when age-adjusted groups of subjects are compared, several optically derived parameters (and in particular always collagen and total hemoglobin content) remain significantly different. Conclusions: Time domain diffuse optical spectroscopy can probe non-invasively breast tissue composition and physiologic blood parameters, and provide information on tissue structure. The measurement is suitable for in vivo studies and monitoring of changes in breast tissue (e.g., with age, lifestyle, chemotherapy, etc.) and to gain insight into related processes, like the origin of cancer risk associated with breast density. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
33. A Model to Predict Upstaging to Invasive Carcinoma in Patients Preoperatively Diagnosed with Low-Grade Ductal Carcinoma In Situ of the Breast.
- Author
-
Nicosia, Luca, Bozzini, Anna Carla, Penco, Silvia, Trentin, Chiara, Pizzamiglio, Maria, Lazzeroni, Matteo, Lissidini, Germana, Veronesi, Paolo, Farante, Gabriel, Frassoni, Samuele, Bagnardi, Vincenzo, Fodor, Cristiana, Fusco, Nicola, Sajjadi, Elham, Cassano, Enrico, and Pesapane, Filippo
- Subjects
- *
BREAST cancer diagnosis , *BREAST cancer surgery , *STATISTICS , *BIOPSY , *ACQUISITION of data methodology , *CANCER invasiveness , *MULTIVARIATE analysis , *MULTIPLE regression analysis , *AGE distribution , *RETROSPECTIVE studies , *DUCTAL carcinoma , *BREAST cancer , *TUMOR classification , *RISK assessment , *CANCER patients , *MEDICAL records , *DESCRIPTIVE statistics , *PREDICTION models , *STATISTICAL models , *CARCINOMA in situ , *TUMOR grading , *DISEASE risk factors - Abstract
Simple Summary: Surgical management is currently the main standard of care procedure used in order to treat ductal carcinoma in situ (DCIS) of the breast. Nevertheless, the survival benefit of surgical resection in patients with such lesions appears to be low, especially for low-grade DCIS. Low-grade DCIS typically exhibit a slow growth pattern and, in many cases, never fully develop into a clinically significant disease: discerning harmless lesions from potentially invasive ones could lead to avoid overtreatment in many patients. Nonetheless, up to 26% of patients with biopsy-proven DCIS can reveal a synchronous invasive carcinoma in surgical specimens. Here, we aimed to create a model of radiological and pathological criteria able to reduce the underestimation of vacuum assisted breast biopsy in DCIS, identifying patients at very low risk (e.g., <2%) of diagnostic underestimation. Background: We aimed to create a model of radiological and pathological criteria able to predict the upgrade rate of low-grade ductal carcinoma in situ (DCIS) to invasive carcinoma, in patients undergoing vacuum-assisted breast biopsy (VABB) and subsequent surgical excision. Methods: A total of 3100 VABBs were retrospectively reviewed, among which we reported 295 low-grade DCIS who subsequently underwent surgery. The association between patients' features and the upgrade rate to invasive breast cancer (IBC) was evaluated by univariate and multivariate analysis. Finally, we developed a nomogram for predicting the upstage at surgery, according to the multivariate logistic regression model. Results: The overall upgrade rate to invasive carcinoma was 10.8%. At univariate analysis, the risk of upgrade was significantly lower in patients with greater age (p = 0.018), without post-biopsy residual lesion (p < 0.001), with a smaller post-biopsy residual lesion size (p < 0.001), and in the presence of low-grade DCIS only in specimens with microcalcifications (p = 0.002). According to the final multivariable model, the predicted probability of upstage at surgery was lower than 2% in 58 patients; among these 58 patients, only one (1.7%) upstage was observed, showing a good calibration of the model. Conclusions: An easy-to-use nomogram for predicting the upstage at surgery based on radiological and pathological criteria is able to identify patients with low-grade carcinoma in situ with low risk of upstaging to infiltrating carcinomas. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
34. Radiomics of MRI for the Prediction of the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Single Referral Centre Analysis.
- Author
-
Pesapane, Filippo, Rotili, Anna, Botta, Francesca, Raimondi, Sara, Bianchini, Linda, Corso, Federica, Ferrari, Federica, Penco, Silvia, Nicosia, Luca, Bozzini, Anna, Pizzamiglio, Maria, Origgi, Daniela, Cremonesi, Marta, and Cassano, Enrico
- Subjects
- *
THERAPEUTIC use of antineoplastic agents , *DRUG efficacy , *DIGITAL image processing , *STATISTICS , *BIOPSY , *CONFIDENCE intervals , *MULTIVARIATE analysis , *MAGNETIC resonance imaging , *RETROSPECTIVE studies , *RANDOM forest algorithms , *CANCER patients , *DESCRIPTIVE statistics , *SYMPTOMS , *COMBINED modality therapy , *LOGISTIC regression analysis , *STATISTICAL models , *RECEIVER operating characteristic curves , *CLUSTER analysis (Statistics) , *HORMONE receptor positive breast cancer , *BREAST tumors , *ALGORITHMS , *EVALUATION - Abstract
Simple Summary: Nowadays, the only widely recognized method for evaluating the efficacy of neoadjuvant chemotherapy is the assessment of the pathological response through surgery. However, delivering chemotherapy to not-responders could expose them to unnecessary drug toxicity with delayed access to other potentially effective therapies. Radiomics could be useful in the early detection of resistance to chemotherapy, which is crucial for switching treatment strategy. We determined whether tumor radiomic features extracted from a highly homogeneous database of breast MRI can improve the prediction of response to chemotherapy in patients with breast cancer, in addiction to biological characteristics, potentially avoiding unnecessary treatment. Objectives: We aimed to determine whether radiomic features extracted from a highly homogeneous database of breast MRI could non-invasively predict pathological complete responses (pCR) to neoadjuvant chemotherapy (NACT) in patients with breast cancer. Methods: One hundred patients with breast cancer receiving NACT in a single center (01/2017–06/2019) and undergoing breast MRI were retrospectively evaluated. For each patient, radiomic features were extracted within the biopsy-proven tumor on T1-weighted (T1-w) contrast-enhanced MRI performed before NACT. The pCR to NACT was determined based on the final surgical specimen. The association of clinical/biological and radiomic features with response to NACT was evaluated by univariate and multivariable analysis by using random forest and logistic regression. The performances of all models were assessed using the areas under the receiver operating characteristic curves (AUC) with 95% confidence intervals (CI). Results: Eighty-three patients (mean (SD) age, 47.26 (8.6) years) were included. Patients with HER2+, basal-like molecular subtypes and Ki67 ≥ 20% presented a pCR to NACT more frequently; the clinical/biological model's AUC (95% CI) was 0.81 (0.71–0.90). Using 136 representative radiomics features selected through cluster analysis from the 1037 extracted features, a radiomic score was calculated to predict the response to NACT, with AUC (95% CI): 0.64 (0.51–0.75). After combining the clinical/biological and radiomics models, the AUC (95% CI) was 0.83 (0.73–0.92). Conclusions: MRI-based radiomic features slightly improved the pre-treatment prediction of pCR to NACT, in addiction to biological characteristics. If confirmed on larger cohorts, it could be helpful to identify such patients, to avoid unnecessary treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
35. Unnecessary axillary node dissections in the sentinel lymph node era
- Author
-
Intra, Mattia, Rotmensz, Nicole, Mattar, Denise, Gentilini, Oreste D., Vento, Annarita, Veronesi, Paolo, Colleoni, Marco, De Cicco, Concetta, Cassano, Enrico, Luini, Alberto, and Veronesi, Umberto
- Subjects
- *
LYMPH nodes , *DISSECTION , *AXILLA , *BREAST cancer - Abstract
Abstract: In the sentinel lymph node era, axillary lymph node dissection (ALND) for uninvolved axillary lymph nodes should be considered unnecessary and inappropriate. Between January 2000 and August 2005, 3487 out of 10,031 invasive breast cancer patients consecutively operated at the European Institute of Oncology were considered not suitable for sentinel lymph node biopsy (SNB) and were directly submitted to ALND (‘direct ALND’). In 2875 cases (82%) a variable grade of axillary involvement was shown, while in 612 patients (18%) no evidence of metastatic spreading was documented in the axilla. In particular, the presence of suspicious nodes at pre-operative clinical evaluation of the axilla (191 patients), neoadjuvant treatment (188 patients), large tumour >2 cm (88 patients), multifocality of disease (76 patients), previous excisional biopsy (49 patients), were considered the most frequent contraindications to SNB and led to an ‘unnecessary ALND’. According to the wider extension of the indications for SNB over the time, the number of ‘unnecessary ALNDs’ progressively decreased from 26% (in 2000) to 9% of the ‘direct ALNDs’ (in 2005). As the clinical indications to SNB are progressively extending to encompass most breast cancer patients with non-metastatic disease who were previously excluded, great effort should be made to avoid ‘unnecessary ALNDs’. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
36. Atypical Ductal Hyperplasia after Vacuum-Assisted Breast Biopsy: Can We Reduce the Upgrade to Breast Cancer to an Acceptable Rate?
- Author
-
Nicosia, Luca, Latronico, Antuono, Addante, Francesca, De Santis, Rossella, Bozzini, Anna Carla, Montesano, Marta, Frassoni, Samuele, Bagnardi, Vincenzo, Mazzarol, Giovanni, Pala, Oriana, Lazzeroni, Matteo, Lissidini, Germana, Mastropasqua, Mauro Giuseppe, and Cassano, Enrico
- Subjects
- *
BREAST biopsy , *SURGICAL excision , *BREAST cancer , *HYPERPLASIA , *CARCINOMA in situ , *DIAGNOSIS - Abstract
(1) Background: to evaluate which factors can reduce the upgrade rate of atypical ductal hyperplasia (ADH) to in situ or invasive carcinoma in patients who underwent vacuum-assisted breast biopsy (VABB) and subsequent surgical excision. (2) Methods: 2955 VABBs were reviewed; 141 patients with a diagnosis of ADH were selected for subsequent surgical excision. The association between patients' characteristics and the upgrade rate to breast cancer was evaluated in both univariate and multivariate analyses. (3) Results: the upgrade rates to ductal carcinoma in situ (DCIS) and invasive carcinoma (IC) were, respectively, 29.1% and 7.8%. The pooled upgrade rate to DCIS or IC was statistically lower at univariate analysis, considering the following parameters: complete removal of the lesion (p-value < 0.001); BIRADS ≤ 4a (p-value < 0.001); size of the lesion ≤15 mm (p-value: 0.002); age of the patients <50 years (p-value: 0.035). (4) Conclusions: the overall upgrade rate of ADH to DCIS or IC is high and, as already known, surgery should be recommended. However, ADH cases should always be discussed in multidisciplinary meetings: some parameters appear to be related to a lower upgrade rate. Patients presenting these parameters could be strictly followed up to avoid overtreatment. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
37. Inter-Reader Agreement of Diffusion-Weighted Magnetic Resonance Imaging for Breast Cancer Detection: A Multi-Reader Retrospective Study.
- Author
-
Pesapane, Filippo, Rotili, Anna, Penco, Silvia, Montesano, Marta, Agazzi, Giorgio Maria, Dominelli, Valeria, Trentin, Chiara, Pizzamiglio, Maria, Cassano, Enrico, and Pinker-Domenig, Katja
- Subjects
- *
BREAST tumor diagnosis , *PATIENT aftercare , *STATISTICS , *MAGNETIC resonance imaging , *RETROSPECTIVE studies , *DESCRIPTIVE statistics , *NEEDLE biopsy , *BREAST tumors ,RESEARCH evaluation - Abstract
Simple Summary: The role of magnetic resonance imaging (MRI) in breast cancer has expanded in the last decade, and studies have demonstrated good sensitivity and specificity of diffusion-weighted imaging (DWI), a functional imaging technique reflecting water diffusion properties in tissues. However, clear results about the reproducibility of DWI are still missing. To utilize DWI as a reliable stand-alone technique for breast cancer detection, the inter-reader agreement of the measurement must be assessed. Accordingly, in this study, we assess the inter-reader reproducibility to retrospectively evaluate the agreement of breast cancer detection using DWI as a stand-alone technique. As our results show a good agreement only in expert readers, the assumption that a breast MRI based only on qualitative analysis of DWI, with fewer variables, may be easier for a non-expert reader to learn seems disproved, and future prospective studies should assess the right time for appropriate training for radiologists to investigate the potential role of DWI as a stand-alone method for un-enhanced breast MRI. Purpose: In order to evaluate the use of un-enhanced magnetic resonance imaging (MRI) for detecting breast cancer, we evaluated the accuracy and the agreement of diffusion-weighted imaging (DWI) through the inter-reader reproducibility between expert and non-expert readers. Material and Methods: Consecutive breast MRI performed in a single centre were retrospectively evaluated by four radiologists with different levels of experience. The per-breast standard of reference was the histological diagnosis from needle biopsy or surgical excision, or at least one-year negative follow-up on imaging. The agreement across readers (by inter-reader reproducibility) was examined for each breast examined using Cohen's and Fleiss' kappa (κ) statistics. The Wald test was used to test the difference in inter-reader agreement between expert and non-expert readers. Results: Of 1131 examinations, according to our inclusion and exclusion criteria, 382 women were included (49.5 ± 12 years old), 40 of them with unilateral mastectomy, totaling 724 breasts. Overall inter-reader reproducibility was substantial (κ = 0.74) for expert readers and poor (κ = 0.37) for non- expert readers. Pairwise agreement between expert readers and non-expert readers was moderate (κ = 0.60) and showed a statistically superior agreement of the expert readers over the non-expert readers (p = 0.003). Conclusions: DWI showed substantial inter-reader reproducibility among expert-level readers. Pairwise comparison showed superior agreement of the expert readers over the non-expert readers, with the expert readers having higher inter-reader reproducibility than the non-expert readers. These findings open new perspectives for prospective studies investigating the actual role of DWI as a stand-alone method for un-enhanced breast MRI. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
38. Combination Assessment of Diffusion-Weighted Imaging and T2-Weighted Imaging Is Acceptable for the Differential Diagnosis of Lung Cancer from Benign Pulmonary Nodules and Masses.
- Author
-
Usuda, Katsuo, Ishikawa, Masahito, Iwai, Shun, Iijima, Yoshihito, Motono, Nozomu, Matoba, Munetaka, Doai, Mariko, Hirata, Keiya, Uramoto, Hidetaka, Cassano, Enrico, and Pesapane, Filippo
- Subjects
- *
LUNG disease diagnosis , *REFERENCE values , *SOLITARY pulmonary nodule , *MAGNETIC resonance imaging , *DIFFERENTIAL diagnosis , *LUNG tumors , *DESCRIPTIVE statistics ,LUNG abscesses - Abstract
Simple Summary: The purpose of this study is to determine whether the combination assessment of DWI and T2WI improves the diagnostic ability for differential diagnosis of lung cancer from benign pulmonary nodules and masses (BPNMs). As using the OCV (1.470 × 10−3 mm2/s) for ADC, the sensitivity was 83.9% (220/262), the specificity 63.4% (33/52), and the accuracy 80.6% (253/314). As using the OCV (2.45) for T2 CR, the sensitivity was 89.7% (235/262), the specificity 61.5% (32/52), and the accuracy 85.0% (267/314). In 212 PNMs which were judged to be malignant by both DWI and T2WI, 203 PNMs (95.8%) were lung cancers. In 33 PNMs which were judged to be benign by both DWI and T2WI, 23 PNMs (69.7%) were BPNMs. The combined assessment of DWI and T2WI could judge PNMs more precisely and would be acceptable for differential diagnosis of PNMs. The purpose of this study is to determine whether the combination assessment of DWI and T2-weighted imaging (T2WI) improves the diagnostic ability for differential diagnosis of lung cancer from benign pulmonary nodules and masses (BPNMs). The optimal cut-off value (OCV) for differential diagnosis was set at 1.470 × 10−3 mm2/s for apparent diffusion coefficient (ADC), and at 2.45 for T2 contrast ratio (T2 CR). The ADC (1.24 ± 0.29 × 10−3 mm2/s) of lung cancer was significantly lower than that (1.69 ± 0.58 × 10−3 mm2/s) of BPNM. The T2 CR (2.01 ± 0.52) of lung cancer was significantly lower than that (2.74 ± 1.02) of BPNM. As using the OCV for ADC, the sensitivity was 83.9% (220/262), the specificity 63.4% (33/52), and the accuracy 80.6% (253/314). As using the OCV for T2 CR, the sensitivity was 89.7% (235/262), the specificity 61.5% (32/52), and the accuracy 85.0% (267/314). In 212 PNMs which were judged to be malignant by both DWI and T2WI, 203 PNMs (95.8%) were lung cancers. In 33 PNMs which were judged to be benign by both DWI and T2WI, 23 PNMs (69.7%) were BPNMs. The combined assessment of DWI and T2WI could judge PNMs more precisely and would be acceptable for differential diagnosis of PNMs. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
39. Complete Removal of the Lesion as a Guidance in the Management of Patients with Breast Ductal Carcinoma In Situ.
- Author
-
Nicosia, Luca, di Giulio, Giuseppe, Bozzini, Anna Carla, Fanizza, Marianna, Ballati, Francesco, Rotili, Anna, Lazzeroni, Matteo, Latronico, Antuono, Abbate, Francesca, Renne, Giuseppe, Addante, Francesca, Lucioni, Marco, Cassano, Enrico, Mastropasqua, Mauro Giuseppe, Balić, Marija, and Coventry, Brendon
- Subjects
- *
BREAST cancer surgery , *BIOPSY , *MAMMOGRAMS , *RETROSPECTIVE studies , *DUCTAL carcinoma , *TREATMENT effectiveness , *DESCRIPTIVE statistics , *CARCINOMA in situ - Abstract
Simple Summary: A diagnosis of ductal carcinoma in situ, made on biopsy, is often followed by surgery or radiotherapy because of the risk of an upgrading disease upon subsequent surgical specimens, finding invasive carcinoma. In order to select which patients can be spared overtreatments and alternatively followed with active surveillance, we retrospectively reviewed 2173 vacuum assisted breast biopsies. Our goal was to demonstrate if complete removal of the lesion by biopsy, documented by mammograms, can be a valid criterion to select the patients that can be spared further treatments. The results of our study demonstrate a significant lower upgrading rate of disease when the lesion is completely removed. Thus, performing a mammogram to document the absence of residual lesion following vacuum-assisted breast biopsy (VABB) allows us to reduce overtreatments and to select which patients can be followed with an active surveillance, sparing unjustified public health costs. Background: Considering highly selected patients with ductal carcinoma in situ (DCIS), active surveillance is a valid alternative to surgery. Our study aimed to show the reliability of post-biopsy complete lesion removal, documented by mammogram, as additional criterion to select these patients. Methods: A total of 2173 vacuum-assisted breast biopsies (VABBs) documented as DCIS were reviewed. Surgery was performed in all cases. We retrospectively collected the reports of post-VABB complete lesion removal and the histological results of the biopsy and surgery. We calculated the rate of upgrade of DCIS identified on VABB upon excision for patients with post-biopsy complete lesion removal and for those showing residual lesion. Results: We observed 2173 cases of DCIS: 408 classified as low-grade, 1262 as intermediate-grade, and 503 as high-grade. The overall upgrading rate to invasive carcinoma was 15.2% (330/2173). The upgrade rate was 8.2% in patients showing mammographically documented complete removal of the lesion and 19% in patients without complete removal. Conclusion: The absence of mammographically documented residual lesion following VABB was found to be associated with a lower upgrading rate of DCIS to invasive carcinoma on surgical excision and should be considered when deciding the proper management DCIS diagnosis. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
40. How we provided appropriate breast imaging practices in the epicentre of the COVID-19 outbreak in Italy.
- Author
-
Pesapane, Filippo, Penco, Silvia, Rotili, Anna, Nicosia, Luca, Bozzini, Anna, Trentin, Chiara, Dominelli, Valeria, Priolo, Francesca, Farina, Mariagiorgia, Marinucci, Irene, Meroni, Stefano, Abbate, Francesca, Meneghetti, Lorenza, Latronico, Antuono, Pizzamiglio, Maria, and Cassano, Enrico
- Subjects
- *
COVID-19 pandemic , *BREAST imaging , *COVID-19 , *EMERGENCY management , *BREAST - Abstract
Italy has one of the highest COVID-19 clinical burdens in the world and Lombardy region accounts for more than half of the deaths of the country. Since COVID-19 is a novel disease, early impactful decisions are often based on experience of referral centres. We report the re-organisation which our institute (IEO, European Institute of Oncology), a cancer referral centre in Lombardy, went through to make our breast-imaging division pandemic-proof. Using personal-protective-equipment and innovative protocols, we provided essential breast-imaging procedures during COVID-19 pandemic without compromising cancer outcomes. The emergency management and infection-control-measures implemented in our division protected both the patients and the staff, making this experience useful for other radiology departments dealing with the pandemic. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
41. Optical identification of subjects at high risk for developing breast cancer.
- Author
-
Taroni, Paola, Quarto, Giovanna, Pifferi, Antonio, Ieva, Francesca, Paganoni, Anna Maria, Balestreri, Nicola, Abbate, Francesca, Menna, Simona, Cassano, Enrico, and Cubeddu, Rinaldo
- Subjects
- *
BREAST cancer risk factors , *OPTICAL mammography , *TISSUE analysis , *COLLAGEN , *REGRESSION analysis - Abstract
A time-domain multi wavelength (635 to 1060 nm) optical mammography was performed on 147 subjects with recent x-ray mammograms available, and average breast tissue composition (water, lipid, collagen, oxy- and deoxy-hemoglobin) and scattering parameters (amplitude a and slope b) were estimated. Correlation was observed between optically derived parameters and mammographic density [Breast Imaging and Reporting Data System (BI-RADS) categories], which is a strong risk factor for breast cancer. A regression logistic model was obtained to best identify high-risk (BI-RADS 4) subjects, based on collagen content and scattering parameters. The model presents a total misclassification error of 12.3%, sensitivity of 69%, specificity of 94%, and simple kappa of 0.84, which compares favorably even with intraradiologist assignments of BI-RADS categories. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
42. Non-invasive optical estimate of tissue composition to differentiate malignant from benign breast lesions: A pilot study.
- Author
-
Taroni, Paola, Paganoni, Anna Maria, Ieva, Francesca, Pifferi, Antonio, Quarto, Giovanna, Abbate, Francesca, Cassano, Enrico, and Cubeddu, Rinaldo
- Abstract
Several techniques are being investigated as a complement to screening mammography, to reduce its false-positive rate, but results are still insufficient to draw conclusions. This initial study explores time domain diffuse optical imaging as an adjunct method to classify non-invasively malignant vs benign breast lesions. We estimated differences in tissue composition (oxy- and deoxyhemoglobin, lipid, water, collagen) and absorption properties between lesion and average healthy tissue in the same breast applying a perturbative approach to optical images collected at 7 red-near infrared wavelengths (635-1060 nm) from subjects bearing breast lesions. The Discrete AdaBoost procedure, a machine-learning algorithm, was then exploited to classify lesions based on optically derived information (either tissue composition or absorption) and risk factors obtained from patient's anamnesis (age, body mass index, familiarity, parity, use of oral contraceptives, and use of Tamoxifen). Collagen content, in particular, turned out to be the most important parameter for discrimination. Based on the initial results of this study the proposed method deserves further investigation. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
43. Ultrasound Challenge: Secondary Breast Angiosarcoma Mimicking Lipoma.
- Author
-
Meroni, Stefano, Moscovici, Oana, Menna, Simona, Renne, Giuseppe, Sosnovskikh, Irina, Rossi, Valentina, and Cassano, Enrico
- Subjects
- *
BREAST tumor diagnosis , *SARCOMA , *DIAGNOSIS - Abstract
The article describes the case of a 46-year old woman who presented with a palpable nonmobile mass in the upper inner quadrant of her left breast and was diagnosed to be secondary breast angiosarcoma mimicking lipoma. Results of breast ultrasound and dynamic enhanced breast magnetic resonance imaging (MRI) revealed a hyperechoic oval circumscribed nodule, mass-like lesion and hemmorhagic area. The patient underwent a left mastectomy.
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.